INSP Inspire Medical Systems Inc

  1. Stocks
  2. Healthcare
  3. NYSE: INSP

Price (delayed)

$42

Market cap

$1.21B

P/E Ratio

9.42

Dividend/share

N/A

EPS

$4.46

Enterprise value

$1.14B

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: 92
Relative Profitability: Rel. Profitability: 87

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the ...

Highlights
The P/E is 76% below the last 4 quarters average of 38.0
The company's equity rose by 25% YoY
INSP's EPS has surged by 99% year-on-year but it is down by 10% since the previous quarter
The net income has soared by 97% YoY but it has contracted by 10% from the previous quarter
The company's quick ratio fell by 40% YoY and by 2.5% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inspiremedicalsystems.com
Peers: OFIX

Key stats

What are the main financial stats of INSP

INSP stock price

How has the Inspire Medical Systems stock price performed over time
Intraday
3.86%
1 week
-2.48%
1 month
-23.41%
1 year
-69.55%
YTD
-54.46%
QTD
-18.57%

Financial performance

How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$915.25M
Gross profit
$785.06M
Operating income
$51.32M
Net income
$131.14M
Gross margin
85.8%
Net margin
14.3%
The net income has soared by 97% YoY but it has contracted by 10% from the previous quarter
INSP's net margin has soared by 81% YoY but it is down by 10% QoQ
The gross profit has grown by 10% YoY
Inspire Medical Systems's revenue has increased by 9% YoY

Price vs fundamentals

How does INSP's price correlate with its fundamentals

Growth

What is Inspire Medical Systems's growth rate over time

Valuation

What is Inspire Medical Systems stock price valuation
INSP P/E details
P/E
9.42
P/B
1.52
P/S
1.32
EV/EBIT
17.8
EV/EBITDA
14.24
EV/Sales
1.25
INSP's EPS has surged by 99% year-on-year but it is down by 10% since the previous quarter
The P/E is 76% below the last 4 quarters average of 38.0
The P/B is 89% below the 5-year quarterly average of 13.4 and 59% below the last 4 quarters average of 3.6
The company's equity rose by 25% YoY
The stock's P/S is 90% less than its 5-year quarterly average of 13.2 and 56% less than its last 4 quarters average of 2.9
Inspire Medical Systems's revenue has increased by 9% YoY

Efficiency

How efficient is Inspire Medical Systems business performance
INSP's ROE has soared by 80% year-on-year but it is down by 15% since the previous quarter
INSP's ROA has soared by 76% YoY but it is down by 15% from the previous quarter
INSP's ROIC is down by 24% YoY and by 6% from the previous quarter
INSP's return on sales is down by 19% year-on-year and by 2.8% since the previous quarter

Dividends

What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSP.

Financial health

How did Inspire Medical Systems financials performed over time
The company's quick ratio fell by 40% YoY and by 2.5% QoQ
The current ratio has declined by 30% year-on-year but it rose by 4.3% since the previous quarter
INSP's debt is 96% lower than its equity
The company's equity rose by 25% YoY
INSP's debt to equity is down by 20% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.